Stay updated on Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial page.

Latest updates to the Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page’s footer revision indicator was updated from v3.5.2 to v3.5.3, reflecting a system/site version change rather than a change to the clinical trial record itself.SummaryDifference0.1%

- Check27 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 from the study history page.SummaryDifference0.1%

- Check55 days agoChange DetectedAdded revision v3.5.0 to the history and removed revision v3.4.3.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded Revision: v3.4.3 to the record history and removed Revision: v3.4.2.SummaryDifference0.1%

- Check91 days agoChange DetectedThe page history shows a new revision tag (v3.4.2) and the removal of a prior government funding status notice, which do not affect study data or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check98 days agoChange DetectedA new version entry (Revision: v3.4.1) was added to the record history, along with a site-wide notice about government funding and operating status; the previous version (v3.4.0) was removed from this history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

Stay in the know with updates to Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial page.